Novel therapeutic target for non-Hodgkin's lymphoma identifiedNovember 23rd, 2009 WASHINGTON - Scientists from Weill Cornell Medical College claim to have identified potential therapeutic target for non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells. The research team insists with the newly discovered mechanism they could powerfully suppress tumour formation in lab testing and in animal models.
Common pain relief drugs promote cancer growthNovember 19th, 2009 WASHINGTON - A new study has revealed that common pain relief medication such as morphine can actually encourage the growth and spread of cancer cells. Opiate-based painkillers have been shown to stimulate cancer growth.
Seeing is relieving, when it comes to relief from chronic painOctober 30th, 2009 WASHINGTON - People who suffer from chronic pain can greatly improve their condition just by looking at the area where the pain is occurring, reveals an Anglo-Italian study. For the study, thirty healthy subjects were invited to look at either their own hand, the experimenter's hand, or an object, while their hand was subjected to laser-induced pain.
Why antidepressants don't work for most peopleOctober 25th, 2009 WASHINGTON - More than half of the people who take anti-depressants never get relief. This is because the cause of depression has been oversimplified and drugs designed to treat it aim at the wrong target, according to a new study.
Why don't anti-depressants work for most people?October 24th, 2009 WASHINGTON - More than half the people who take anti-depressants seldom get relief. A bnew study says this is because drugs designed to treat depression aim at the wrong target.
Brain structures behind emotional balance in threatening situations identifiedOctober 22nd, 2009 WASHINGTON - A primitive region of the brain, which is behind sensorimotor control, also plays an important role in regulating emotional responses to threatening situations, say researchers at Georgetown University Medical Center. This region appears to work in concert with another structure called the amygdala to regulate social and emotional behaviour.
New finding may provide novel therapeutic targets for depressionOctober 19th, 2009 WASHINGTON - Georgetown University Medical Center researchers have clarified how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated - a finding that may provide new therapeutic targets for depression. Drugs currently used to treat depression target the regulatory process for neurotransmitters, and while effective in some cases, do not appear to work in other cases.
Potential therapeutic target for lung diseases identifiedOctober 16th, 2009 WASHINGTON - Scientists from Washington University School of Medicine in St. Louis, McGill University have identified a genetic mutation that might open avenues for developing novel treatments for children born with lung distress and chronic obstructive pulmonary disease (COPD).
New therapeutic target for Alzheimer's identifiedOctober 8th, 2009 WASHINGTON - A Purdue University researcher has identified a potential therapeutic target for Alzheimer's disease. Researcher Sandra Rossie, a professor of biochemistry, found that the amount of an enzyme present in neurons can affect the mechanism thought to cause cell death in Alzheimer's disease patients and may have applications for other diseases such as stroke and heart attack.
Antibiotic could be the new stroke treatmentOctober 6th, 2009 WASHINGTON - The antibiotic minocycline may offer new and more effective treatment for stroke patients, says a new study. The research, published in the open access journal BMC Neuroscience, describes the safety and therapeutic efficacy of the drug in animal models.
Novel therapeutic target for fatal flu lung complication identifiedSeptember 30th, 2009 WASHINGTON - Researchers from Louisiana State University Health Sciences Center have identified a new target that for preventing fatal flu lung complication. The study showed that the novel target could help prevent acute lung injury resulting in acute respiratory distress syndrome, a highly fatal complication of influenza infection.
Gene that could lead to new therapies for bone marrow disease identifiedSeptember 29th, 2009 WASHINGTON - Scientists from Van Andel Research Institute (VARI) have identified a gene that helps in progression of Myelodysplastic Syndrome (MDS), a bone marrow disease. They believe that the new gene called RhoB could prove to be a therapeutic target for late-stage MDS.
New gene may provide better immune defense against anthraxSeptember 9th, 2009 WASHINGTON - Scientists from University of California have identified a gene in anthrax-causing bacteria that could be used as a potential therapeutic target for the deadly disease. The ClpX gene in bacterium Bacillus anthracis not only contributes to the severity of the anthrax disease but also makes it more difficult for a patient's immune system to fight the infection.
Scientists imitate viruses to deliver therapeutic genesSeptember 1st, 2009 WASHINGTON - Australian scientists have developed a new gene therapy vector that uses the same machinery as viruses to transport their cargo into cells. David Jans, from the Nuclear Signaling Laboratory at Monash University in Victoria, says that this achievement has raised the hope that one day therapeutic DNA will begin to be transferred to a cell's nucleus far more efficiently than in the past, and thus there will be more effective treatments for several genetic disorders and some types of cancers.
Novel therapeutic target for Parkinson's disease identifiedAugust 29th, 2009 WASHINGTON - Scientists from University of Helsinki Institute of Biotechnology have identified a novel therapeutic target for Parkinson's disease. Lead researcher Professor Raimo K.
